Connection
Laurel Messer to Cost-Benefit Analysis
This is a "connection" page, showing publications Laurel Messer has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.048 |
|
|
|
-
Al Rawashdh N, Patel BV, Wang SM, Zur RM, Anaya P, Kahn EB, Pinsker JE, Sasson-Katchalski R, Trahan AC, Messer LH, Assadi K, Kudva YC, Beck RW. Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States. Diabetes Obes Metab. 2026 Jul; 28(7):6280-6290.
Score: 0.048